The residency is a 12-month, ASHP-pre-accredited, post-graduate program
that begins around July 1 annually. We accept one resident yearly. Application
deadline is Jan. 15. Early commit for KD PGY1 resident available.
The PGY2 resident will staff every third weekend in the clinical pharmacy
office. Activities include order verification and dosing of antimicrobials,
antibiotic timeouts, and culture result reviews.
PROGRAM COMPLETION REQUIREMENTS
Participation in ASHP Midyear Conference
Presentation at a regional or national conference
Completion of a quality improvement project
Completion of a year-long research project
Preparation of a research manuscript
Presentation of two ACPE-approved CEs
Completion of a teaching certificate program if not completed during PGY1
(offered through the Marshall University School of Pharmacy)
STIPEND
PGY2: $56,678
JACOB OSBORNE, PHARM.D., MBA PGY2 Infectious Diseases Resident 2023-24
Dr. Osborne is the current PGY2 Pharmacy Resident in Infectious Diseases
and a 2022 graduate of the University of Kentucky College of Pharmacy.
He also earned his Master in Business Administration from the University
of Kentucky Gatton College of Business in 2022. He completed his PGY-1
residency at KDMC in 2023. Dr. Osborne’s areas of research interest
are antimicrobial stewardship, HIV medication management, and Hepatitis
C screening initiatives. Upon completion of the PGY2 residency, Dr. Osborne
plans to work in an Infectious Diseases clinic and assist in the treatment
of patients infected with HIV and/or Hepatitis C.
Dr. Osborne is the current PGY2 Pharmacy Resident in Infectious Diseases
and a 2022 graduate of the University of Kentucky College of Pharmacy.
He also earned his Master in Business Administration from the University
of Kentucky Gatton College of Business in 2022. He completed his PGY-1
residency at KDMC in 2023. Dr. Osborne’s areas of research interest
are antimicrobial stewardship, HIV medication management, and Hepatitis
C screening initiatives. Upon completion of the PGY2 residency, Dr. Osborne
plans to work in an Infectious Diseases clinic and assist in the treatment
of patients infected with HIV and/or Hepatitis C.
